The Highland Meeting in Utah on May 20, 2023, focused on discussions surrounding the controversial topic of mRNA injections, particularly in the context of the COVID-19 pandemic. The meeting featured Kirk Moore, who expressed strong opposition to the vaccines and shared his experiences as a healthcare provider during the pandemic.
Moore began by recounting the rapid changes in public health guidelines, noting the confusion surrounding mask mandates and the shifting narrative on COVID-19 treatments. He highlighted a pivotal moment in October 2020 when the health department's authority to enforce mask mandates on children was rescinded, a decision that sparked significant backlash.
As the pandemic progressed, Moore described how many patients struggled to receive timely medical care. He recounted prescribing hydroxychloroquine and Zithromax to patients who were unable to access treatment, emphasizing the desperation he witnessed among those suffering from COVID-19 symptoms.
Moore expressed skepticism about the speed at which the COVID-19 vaccines were developed, comparing it unfavorably to the lengthy efforts to create vaccines for diseases like cancer and HIV. He raised concerns about the lack of comprehensive studies, particularly animal trials, which he claimed resulted in the deaths of test subjects. This led him to conclude that the vaccines were being rolled out without adequate safety assurances, framing the situation as a "science experiment" on the public.
Throughout the meeting, Moore's remarks underscored a broader sentiment of distrust towards government health mandates and the pharmaceutical industry. His perspective resonated with attendees who share similar concerns about personal freedoms and medical autonomy.
The meeting concluded without any formal resolutions but highlighted the ongoing debate over vaccine safety and public health policy in Utah. Participants left with a heightened awareness of the issues surrounding mRNA injections and the implications for individual rights in healthcare decisions.